Speaker: Naveen Pemmaraju Prof. Naveen Pemmaraju completed his Internal Medicine training at Johns Hopkins, in the Osler Medical Program, he subsequently completed both hematology and oncology training at MD Anderson Cancer Center (MDACC). He was selected as a chief fellow in his second year of training. He obtained ABIM board certification in Internal Medicine, Hematology and Oncology, and continued his career at MDACC as an Assistant Professor in the Department of Leukemia. His clinical/translational research work has been focused on improving outcomes and developing novel therapies for patients with rare myeloid malignancies, including for adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Myeloproliferative Neoplasms (MPN) and Acute Myeloid Leukemia (AML).